HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Luminol

5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations.
Also Known As:
1,4-Phthalazinedione, 5-amino-2,3-dihydro-
Networked: 278 relevant articles (4 outcomes, 29 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yüksel, Meral: 4 articles (03/2010 - 09/2005)
2. Farkhutdinov, U R: 4 articles (08/2007 - 01/2000)
3. Yuksel, M: 3 articles (10/2015 - 03/2007)
4. Scofield, Virginia L: 3 articles (02/2012 - 02/2009)
5. Kuang, Xianghong: 3 articles (02/2012 - 02/2009)
6. Wong, Paul K Y: 3 articles (02/2012 - 02/2009)
7. Ye─čen, Berrak C: 3 articles (03/2010 - 10/2006)
8. Agarwal, Ashok: 2 articles (12/2015 - 11/2009)
9. Sharma, Rakesh: 2 articles (12/2015 - 11/2009)
10. Gabbasov, Zufar: 2 articles (01/2014 - 01/2010)

Related Diseases

1. Inflammation
2. Infection
3. Sarcoidosis (Schaumann Disease)
4. Fibrosis (Cirrhosis)
12/01/2000 - "Histological examination of the kidney revealed a significant reduction in glomerular sclerosis, tubular injury, luminol protein cast accumulation, and interstitial fibrosis as well as urinary protein. "
08/01/1994 - "The reduction of Cypridina luciferin analog-dependent chemiluminescence in chronic active hepatitis and cirrhosis was more sensitive than Cypridina luciferin analog-dependent chemiluminescence; however, in hepatocellular carcinoma, luminol-dependent chemiluminescence was more reduced than luminol-dependent chemiluminescence. "
08/01/1994 - "Both Cypridina luciferin analog-dependent chemiluminescence and luminol-dependent chemiluminescence were significantly decreased in neutrophils from patients with chronic liver disease (hepatocellular carcinoma < cirrhosis < chronic active hepatitis) when they were compared with normal healthy subjects. "
07/18/2008 - "Pirfenidone (PFD) is focused on a new anti-fibrotic drug, which can minimize lung fibrosis etc. We evaluated the superoxide (O2*-) scavenging activities of PFD and the PFD-iron complex by electron spin resonance (ESR) spectroscopy, luminol-dependent chemiluminescence assay, and cytochrome c reduction assay. "
08/01/1994 - "To evaluate whether neutrophil bactericidal function, the ability to produce oxygen-derived free radicals, is altered in patients with chronic liver disease, we measured chemiluminescence amplified by a luciferin analog (Cypridina luciferin analog-dependent chemiluminescence) and luminol (luminol-dependent chemiluminescence) in response to N-formyl-Met-Lue-Phe by neutrophils from patients with chronic liver diseases due to C and/or B type hepatitis: chronic active hepatitis, cirrhosis and hepatocellular carcinoma. "
5. Sclerosis

Related Drugs and Biologics

1. Zymosan
2. Reactive Oxygen Species (Oxygen Radicals)
3. Oxygen
4. Tetradecanoylphorbol Acetate
5. 10,10'-dimethyl-9,9'-biacridinium (Lucigenin)
6. Peroxidase (Myeloperoxidase)
7. Superoxides (Superoxide)
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
9. Free Radicals
10. Cytokines

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
3. Microspheres (Microsphere)
4. Intraperitoneal Injections
5. Renal Dialysis (Hemodialysis)